| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 6.703 | 10.872 | 25.264 | 119.761 | 454.094 | 234.713 |
| Total Income - EUR | - | - | - | 0 | 6.703 | 10.872 | 25.264 | 119.761 | 459.451 | 237.766 |
| Total Expenses - EUR | - | - | - | 6.561 | 14.316 | 10.383 | 18.330 | 35.562 | 89.695 | 134.222 |
| Gross Profit/Loss - EUR | - | - | - | -6.561 | -7.613 | 489 | 6.934 | 84.199 | 369.756 | 103.544 |
| Net Profit/Loss - EUR | - | - | - | -6.566 | -7.862 | 236 | 6.202 | 81.860 | 365.247 | 96.463 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medart Excellence S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 28.722 | 27.391 | 22.944 | 20.279 | 18.292 | 127.942 | 94.539 |
| Current Assets | - | - | - | 16.795 | 14.959 | 14.559 | 17.320 | 78.213 | 377.420 | 137.236 |
| Inventories | - | - | - | 16.581 | 14.706 | 14.475 | 16.725 | 1.574 | 5.962 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 20.803 | 266.241 | 35.565 |
| Cash | - | - | - | 214 | 253 | 84 | 595 | 55.836 | 105.217 | 101.671 |
| Shareholders Funds | - | - | - | -6.523 | -13.943 | -13.443 | -6.942 | 74.897 | 365.288 | 96.503 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 52.040 | 56.293 | 50.946 | 44.541 | 21.609 | 140.074 | 135.272 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medart Excellence S.r.l.